Learn how to develop and maintain an effective and innovative business model to stand out and find success in the medtech industry.
We are committed to ensuring that our mission is not compromised by the perpetuation of racial health disparities.
The 17th edition of EY’s Pulse of the Industry report offers a chance to take stock of the US and European medtech industry’s performance in 2023.
Medicare beneficiaries stand to gain greatly from the ethical development and use of artificial intelligence (AI) and software solutions that improve the diagnosis and treatment of illness and disability, promote…
This report focuses on coverage for devices and issues related to procedural delays, the lack of transparency in Medicare’s National Coverage Determination process, the use of Coverage with Evidence Development,…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
This AdvaMed position statement is intended to provide clarity about the transition away from the acronyms NDC/NHRIC to NRC, including rationale and implications.
AdvaMed Response to Senate HELP Committee Regarding Reauthorization of Pandemic All-Hazards Preparedness Act
On March 29, AdvaMed responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA).
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.